{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    4,
    5,
    6,
    10,
    11,
    12,
    13,
    14,
    29,
    30,
    31,
    32,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "AZD7442",
        "type": {
          "id": "34d6fc87-38c0-41e6-b12a-a9df055523b9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "58f4228f-139b-4df4-a27b-b30e27e76867",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "A combination product of 2 monoclonal antibodies (AZD8895 and AZD1061) for the treatment of COVID-19.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Saline placebo",
        "type": {
          "id": "c4e71996-b20e-4176-9d50-f0e2ac9162c6",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "b99cfd67-d090-43ee-b32d-09b2634ff510",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Visually distinct saline solution administered as 2 separate 3 mL IM injections.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Local standard of care",
        "type": {
          "id": "249e4005-e281-4f64-8770-f8efd1ab8c07",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "7d8e1a71-73b4-4b43-9780-a56910cfd6f7",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Background therapy according to participating institution/hospital regardless of randomization group.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Influenza vaccines",
        "type": {
          "id": "f49cefa8-3193-4d8b-b0ab-5501fbd14998",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "be0a6e6e-36c5-4fd0-8b0d-948966c63303",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Licensed influenza vaccines are permitted at any time.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Allergen immunotherapy",
        "type": {
          "id": "98289c7e-2ca0-4598-b74a-6e88e22edb8d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "035dc4a5-2378-4b0b-b0bc-8eb5d16880a0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Allowed if participant has been receiving stable desensitization therapy for at least 30 days prior to Day 1."
      },
      {
        "id": "int_6",
        "name": "Commercial biologics/immunosuppressants",
        "type": {
          "id": "c03ff5c0-54b2-4373-b581-cab4e1f4d37f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9745ea7e-ba21-42d8-a21d-ac3e0a64fbe7",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Includes prednisone, azathioprine, tacrolimus, cyclosporine, methotrexate, hydroxychloroquine, or cytotoxic chemotherapy if stable on maintenance dose."
      },
      {
        "id": "int_7",
        "name": "SARS-CoV-2 vaccines",
        "type": {
          "id": "f0540612-77ec-4a67-b0ba-787eb5175d3f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "31360cc6-800d-4c68-952d-0b97fcf004a8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited prior to study entry; restricted during acute illness; requires unblinding and counseling if requested after recovery."
      },
      {
        "id": "int_8",
        "name": "Convalescent COVID-19 plasma",
        "type": {
          "id": "f2fe939f-fab1-4395-8c77-c4b01dc0cc08",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "824dd996-5f83-47da-9c3c-06594687e16d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited at any time prior to study entry."
      },
      {
        "id": "int_9",
        "name": "Systemic or inhaled steroids",
        "type": {
          "id": "d05bee01-f3de-4827-bd77-8b0916190266",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0d78b109-7755-4c81-a8a0-1cdd5c643dd8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 30 days prior to study entry unless a stable dose is used for a chronic condition."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "AZD8895",
        "administrableDoseForm": {
          "id": "87e01ebe-cc95-4214-bd3b-c08d8033db27",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "7e39ab62-870c-4ed9-814d-b4b5fa80014a",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "692bf2e1-2964-4880-ac6a-8907edeb40d5",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AstraZeneca"
      },
      {
        "id": "prod_2",
        "name": "AZD1061",
        "administrableDoseForm": {
          "id": "4c8a0cf0-5530-4672-94f1-fa9ef0574cbd",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "9d7198ad-c36f-46d1-8888-011b80b7249e",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "80b91854-0ad7-40e5-845b-adbec691cf58",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 mg/mL",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "AstraZeneca"
      },
      {
        "id": "prod_3",
        "name": "Saline placebo",
        "administrableDoseForm": {
          "id": "58038a8d-879d-4d1e-aaed-a1922a0e1664",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "7d3aa46a-e443-4879-90e2-01311d5dffdc",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "79ffa896-0128-4a65-886f-28486098b1c8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "0.9% w/v",
        "manufacturer": "AstraZeneca"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "AZD7442 600 mg IM",
        "instanceType": "Administration",
        "dose": "600 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Day 1 only (monitored for 456 days)"
      },
      {
        "id": "admin_2",
        "name": "AZD8895 component",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "id": "admin_3",
        "name": "AZD1061 component",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "id": "admin_4",
        "name": "Placebo administration",
        "instanceType": "Administration",
        "dose": "6 mL total",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Two separate 3 mL injections in the gluteal region"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "AZD8895",
        "instanceType": "Substance",
        "description": "Monoclonal antibody component of AZD7442"
      },
      {
        "id": "sub_2",
        "name": "AZD1061",
        "instanceType": "Substance",
        "description": "Monoclonal antibody component of AZD7442"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 9,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "AZD7442",
        "role": "Investigational Product",
        "description": "A combination product of 2 monoclonal antibodies (AZD8895 and AZD1061) for the treatment of COVID-19."
      },
      {
        "name": "Saline placebo",
        "role": "Placebo",
        "description": "Visually distinct saline solution administered as 2 separate 3 mL IM injections."
      },
      {
        "name": "Local standard of care",
        "role": "Background Therapy",
        "description": "Background therapy according to participating institution/hospital regardless of randomization group."
      },
      {
        "name": "Influenza vaccines",
        "role": "Concomitant Medication",
        "description": "Licensed influenza vaccines are permitted at any time."
      },
      {
        "name": "Allergen immunotherapy",
        "role": "Concomitant Medication",
        "description": "Allowed if participant has been receiving stable desensitization therapy for at least 30 days prior to Day 1."
      },
      {
        "name": "Commercial biologics/immunosuppressants",
        "role": "Concomitant Medication",
        "description": "Includes prednisone, azathioprine, tacrolimus, cyclosporine, methotrexate, hydroxychloroquine, or cytotoxic chemotherapy if stable on maintenance dose."
      },
      {
        "name": "SARS-CoV-2 vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited prior to study entry; restricted during acute illness; requires unblinding and counseling if requested after recovery."
      },
      {
        "name": "Convalescent COVID-19 plasma",
        "role": "Concomitant Medication",
        "description": "Prohibited at any time prior to study entry."
      },
      {
        "name": "Systemic or inhaled steroids",
        "role": "Concomitant Medication",
        "description": "Prohibited within 30 days prior to study entry unless a stable dose is used for a chronic condition."
      }
    ],
    "products": [
      {
        "name": "AZD8895",
        "doseForm": "Injection",
        "strength": "100 mg/mL",
        "manufacturer": "AstraZeneca"
      },
      {
        "name": "AZD1061",
        "doseForm": "Injection",
        "strength": "100 mg/mL",
        "manufacturer": "AstraZeneca"
      },
      {
        "name": "Saline placebo",
        "doseForm": "Injection",
        "strength": "0.9% w/v",
        "manufacturer": "AstraZeneca"
      }
    ],
    "substances": [
      {
        "name": "AZD8895",
        "description": "Monoclonal antibody component of AZD7442"
      },
      {
        "name": "AZD1061",
        "description": "Monoclonal antibody component of AZD7442"
      }
    ],
    "administrations": [
      {
        "name": "AZD7442 600 mg IM",
        "dose": "600 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Day 1 only (monitored for 456 days)"
      },
      {
        "name": "AZD8895 component",
        "dose": "300 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "name": "AZD1061 component",
        "dose": "300 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "name": "Placebo administration",
        "dose": "6 mL total",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Two separate 3 mL injections in the gluteal region"
      }
    ],
    "devices": []
  }
}